Recognizing the importance of identifying new biomedical interventions and integrating state-of-the-art methods and technologies to the research priority areas, this working group includes expertise in the areas of antiretrovirals (ARV) for prevention, Multipurpose Prevention Treatments (MPT) and broadly neutralizing antibodies (bnAbs). The Working Group brings expertise in developing and testing novel products and delivery systems.
(Chair)
(Co-Chair)
Members
- Elaine Abrams
- Myron Cohen (EC Rep)
- Leslie Cottle (SDMC Rep)
- Sue Eshleman (LC Rep)
- Jessica Justman
- Craig Hendrix
- Betsy Herold
- Sharon L. Hillier - Multi-Purpose Technology (MPT) Lead
- Richard Koup
- Lynn Morris
- Deenan Pillay
- Stephen Wakefield (EWG Liason)
Biomedical Sciences Working Group Group Contact
- Ayana Moore, FHI 360